Findings of Misconduct by a then Drug Enforcement Administration Regional Director for Misuse of Sensitive Investigative Unit Funds, Misuse of Representation Funds, Lack of Candor in Request for Representation Funds, and Related Misconduct
- NARA ID
- findings-misconduct-then-drug-enforcement-administration-regional-director-misuse-sensitive
- Source
- oig-doj
- Collection
- DOJ OIG — Drug Enforcement Administration
- Agency
- U.S. DOJ Office of the Inspector General
- Classification
- Investigation
- Released
- 2023-01-25
- Slug
- doj-oig-findings-misconduct-then-drug-enforcement-administration-regional-director-misuse-sensitive
- Indexed
- 2026-04-27 05:02:03
More from DOJ OIG — Drug Enforcement Administration
- Audit of the Drug Enforcement Administration’s Mobile Enforcement Team Program
- Audit of the Drug Enforcement Administration's Management and Oversight of its Confidential Source Program
- Audit of the Drug Enforcement Administration's Language Services Contract with SOS International, Ltd., Contract Number DJDEA-05-C-0020, Dallas Field Division
- Audit of the Drug Enforcement Administration's Aviation Operations
- Management Advisory Memorandum – Notification of Concerns Relating to the DEA’s Untimely Reporting of Potential Human Rights Violations by Foreign Law Enforcement
- Audit of the Drug Enforcement Administration’s Laboratory Information Management System Support Contracts
Browse all 60 documents in DOJ OIG — Drug Enforcement Administration →
About the DOJ OIG — Drug Enforcement Administration collection
U.S. DOJ Office of the Inspector General reports (audits, investigations, evaluations, and reviews) concerning Drug Enforcement Administration.